000 01126 a2200373 4500
005 20250517221159.0
008 ####s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.24378
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSun, Bowen
245 0 0 _aOridonin inhibits aberrant AKT activation in breast cancer.
_h[electronic resource]
260 _bOncotarget
_cMay 2018
300 _a23878-23889 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aWang, Geng
700 1 _aLiu, Huidong
700 1 _aLiu, Pian
700 1 _aTwal, Waleed O
700 1 _aCheung, Hiuwing
700 1 _aCarroll, Steven L
700 1 _aEthier, Stephen P
700 1 _aMevers, Emily E
700 1 _aClardy, Jon
700 1 _aRoberts, Thomas
700 1 _aChen, Changbin
700 1 _aLi, Qian
700 1 _aWang, Lanfeng
700 1 _aYang, Meixiang
700 1 _aZhao, Jean J
700 1 _aWang, Qi
773 0 _tOncotarget
_gvol. 9
_gno. 35
_gp. 23878-23889
856 4 0 _uhttps://doi.org/10.18632/oncotarget.24378
_zAvailable from publisher's website
999 _c28473711
_d28473711